Systematic identification of p11 as a signaling modulator across the GPCRome.

Saarinen M, Kotliar IB, Höffkes I, Branzell N, Bowin CF, Dahl L, Da Silva E, Glaros V, Abney A, Bendes A, Kreslavsky T, Schwenk JM, Sakmar TP, Svenningsson P

Sci Adv 12 (40) eaeg6567 [2026-10-02; online 2026-09-30]

The microprotein p11 (S100A10) is a ubiquitously expressed molecular scaffold that is known to be required for behavioral responses to certain antidepressants, presumably through its effect on G protein-coupled receptor (GPCR)-mediated signaling. Here, we demonstrate that p11 recruitment to GPCRs is promoted by an active receptor conformation. Furthermore, by mapping the GPCR-p11 interactome using a multiplexed suspension bead array (SBA) of 211 receptors, we identified more than two dozen high-confidence physical interactors across diverse GPCR signaling families. We define the functional significance of these interactions by focusing on a novel SBA screening hit, the protease-activated receptor 2 (PAR2). Transcriptomic fingerprinting and signaling assays in p11-knockout cells reveal that p11 acts as an amplifier of endogenous PAR2 signaling. PAR2 and p11 are specifically coexpressed in vivo in a subset of sensory neurons, and p11-deficient mice exhibit a blunted PAR2-mediated inflammatory response. Our results establish p11 as a widespread, activity-dependent modulator of GPCR-mediated signaling outcomes across diverse physiological processes.

CRISPR Functional Genomics [Service]

PubMed 42814836

DOI 10.1126/sciadv.aeg6567

Crossref 10.1126/sciadv.aeg6567

pmc: PMC13626081


Publications 9.5.1